Logo

Hemophilia A Cochrane Pediatric Emergency Medicine Reviews

Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Visit

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Visit

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.

OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.